Aspirin Ad Claims For Cardiovascular Benefits Allowed In UK Proposal
This article was originally published in The Tan Sheet
Executive Summary
Promoting aspirin 75 mg to consumers for secondary prevention of heart attack or stroke would be permitted in the UK under a proposal issued for consultation by the country's Medicines Control Agency Nov. 4